Heberprot-P: use in diabetic foot

Heberprot-P: use in diabetic foot

Here is described the treatment of a Venezuela female patient, who was diagnosed whith an ischemic diabetic foot, caused by a lasion on the top of the left foot. The metabolic parameters were stabilized after treatment. The infection of the lesion was controlled, and the wound was debrided, and furt...

Full description

Bibliographic Details
Main Authors: Cecilio González, Julio Baldomero, Liubka María Pérez, Nancy Paredes, Aída R Hernández, Exavier Campos, Felipe Piñol
Format: Article
Language:English
Published: Elfos Scientiae
Series:Biotecnología Aplicada
Subjects:
pie diabético
heberprot-p
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&lng=en&tlng=en
id doaj-48f712267c904dd09cc01aa87b88e272
record_format Article
spelling doaj-48f712267c904dd09cc01aa87b88e2722020-11-25T03:12:07ZengElfos ScientiaeBiotecnología Aplicada1027-2852272177178S1027-28522010000200014Heberprot-P: use in diabetic footCecilio González0Julio Baldomero1Liubka María Pérez2Nancy Paredes3Aída R Hernández4Exavier Campos5Felipe Piñol6Hospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHospital Provincial Clínico-Quirúrgico Docente Arnaldo Milián CastroHere is described the treatment of a Venezuela female patient, who was diagnosed whith an ischemic diabetic foot, caused by a lasion on the top of the left foot. The metabolic parameters were stabilized after treatment. The infection of the lesion was controlled, and the wound was debrided, and further treated with 75 µg Heberprot-P until complete closure for 92 days, with 29 doses of the product.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&lng=en&tlng=enpie diabéticoheberprot-p
collection DOAJ
language English
format Article
sources DOAJ
author Cecilio González
Julio Baldomero
Liubka María Pérez
Nancy Paredes
Aída R Hernández
Exavier Campos
Felipe Piñol
spellingShingle Cecilio González
Julio Baldomero
Liubka María Pérez
Nancy Paredes
Aída R Hernández
Exavier Campos
Felipe Piñol
Heberprot-P: use in diabetic foot
Biotecnología Aplicada
pie diabético
heberprot-p
author_facet Cecilio González
Julio Baldomero
Liubka María Pérez
Nancy Paredes
Aída R Hernández
Exavier Campos
Felipe Piñol
author_sort Cecilio González
title Heberprot-P: use in diabetic foot
title_short Heberprot-P: use in diabetic foot
title_full Heberprot-P: use in diabetic foot
title_fullStr Heberprot-P: use in diabetic foot
title_full_unstemmed Heberprot-P: use in diabetic foot
title_sort heberprot-p: use in diabetic foot
publisher Elfos Scientiae
series Biotecnología Aplicada
issn 1027-2852
description Here is described the treatment of a Venezuela female patient, who was diagnosed whith an ischemic diabetic foot, caused by a lasion on the top of the left foot. The metabolic parameters were stabilized after treatment. The infection of the lesion was controlled, and the wound was debrided, and further treated with 75 µg Heberprot-P until complete closure for 92 days, with 29 doses of the product.
topic pie diabético
heberprot-p
url http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200014&lng=en&tlng=en
work_keys_str_mv AT ceciliogonzalez heberprotpuseindiabeticfoot
AT juliobaldomero heberprotpuseindiabeticfoot
AT liubkamariaperez heberprotpuseindiabeticfoot
AT nancyparedes heberprotpuseindiabeticfoot
AT aidarhernandez heberprotpuseindiabeticfoot
AT exaviercampos heberprotpuseindiabeticfoot
AT felipepinol heberprotpuseindiabeticfoot
_version_ 1724651438420787200

Similar Items